Hosted on MSN1mon
The shortage of popular weight loss drug tirzepatide is over, FDA says. Patients could see higher costs as a result.
The FDA has announced that popular weight loss medication tirzepatide is no longer in shortage, potentially removing cheaper versions of the drug from the market by early 2025. Tirzepatide is the ...
Hosted on MSN1mon
FDA says tirzepatide shortage is over after taking a second look
The Food and Drug Administration said Thursday it’s standing by its earlier decision that the shortage of tirzepatide — the active ingredient in Eli Lilly’s diabetes and weight loss drugs Mo ...
Healthline5d
Mounjaro Injection Overview
Mounjaro (tirzepatide) is a prescription drug used to help manage blood sugar levels in adults with type 2 diabetes. Mounjaro comes as an injection that’s given under your skin. This medication ...
pharmaphorum10d
Trials set up filing for Lilly’s tirzepatide in sleep apnoea
Eli Lilly’s diabetes and obesity therapy tirzepatide could find a use as a ... Sun Pharma's Taro unit has made a bid to acquire Canadian biotech Antibe, a developer of drugs for pain and ...
Yahoo1mon
The shortage of popular weight loss drug tirzepatide is over, FDA says. Patients could see higher costs as a result.
Tirzepatide, the active ingredient in Zepbound and Mounjaro, is no longer in short supply, the FDA says. Cheaper versions of the drug, known as compounded tirzepatide, might be restricted in 2025 ...